People
Creoptix AG announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020.
“We still have some work in front of us, but we’re happy where we are,” said Jeff Hawkins, CEO of Truvian Sciences.
Despite having one of the best-selling insulin products on the market, Sanofi is exiting diabetes and cardiovascular research and development in favor of more lucrative areas, particularly cancer research.
As the 61st American Society of Hematology Annual Meeting wrapped up in Orlando, Florida, there were hundreds of studies and results presented. Here’s a look at some.
Proteona Pte. Ltd. has announced the results of the firstProteona Oncology Challenge, co-sponsored by NovogeneAIT.
Similar to the Biotech Bay list, BioSpace takes a look at the top 10 2019 Life Sciences Ideal Employer Report’s for Genetown.
Shares of Alexion Pharmaceuticals have jumped nearly 5% after the company’s board of directors rejected a push for a sale of the company from one of its largest stakeholders, U.K.-based Elliott Advisors, Ltd.
Veritas Genetics was offering whole-genome sequencing for about $600, going head-to-head with companies like 23andMe and Ancestry.com. Earlier this week there were reports the company laid off 50 staffers and now they’ve announced they are ending operations in the U.S.
Inceptua announced that Paul Wituschek has been appointed President North America.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s hires.
PRESS RELEASES